Compare Ascendis Pharma A/S (ASND) vs Uranium Energy Corp (UEC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Uranium Energy Corp — how do they compare? Ascendis Pharma A/S trades at $255.5 (market cap $16.67B), while Uranium Energy Corp trades at $11.7 (market cap $5.67B). The key difference: Ascendis Pharma A/S is far larger — about 2.9× Uranium Energy Corp's market cap, and Ascendis Pharma A/S is trading nearer its 52-week high, Uranium Energy Corp nearer its low. Which is the better fit depends on your goals.
| ASND | UEC | |
|---|---|---|
Market Cap | $16.67B | $5.67B |
Sector | Health | Energy |
52-Week High | $277.18 | $20.14 |
52-Week Low | $189.74 | $9.04 |
Enterprise Value | $17.04B | $5.18B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Uranium Energy Corp
Uranium Energy Corp is a leading American uranium mining and exploration company, currently holding the largest resource base and licensed production capacity in the United States. Utilizing low-cost, environmentally friendly In-Situ Recovery (ISR) mining, UEC is a central player in the domestic nuclear fuel supply chain, transitioning from a resource holder to an active producer and refiner to meet the accelerating demand for carbon-free energy.
Read more on UEC →
